International Headache Society.- The international classification of headache disorders. 2nd edition. Cephalalgia, 2004, 24 (Suppl 1), 1-160.
Rasmussen BK.- Epidemiology of Headache. Cephalalgia, 2001, 21, 774-777.
Joutel A, Bousser MG, Biousse V, et al.- A gene for familial hemiplegic migraine maps to chromosome 19. Nat Gen, 1993, 5, 40-45.
Ophoff RA, Terwindt GM, Vergouwe MN, et al.- Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell, 1996, 87, 543-552.
Sandor PS, Ambrosini A, Agosti R, Schoenen J.- Genetics of migraine: possible links to neurophysiological abnormalities. Headache, 2002, 42, 365-377.
Pavlakis SG, Phillips PC, Di Mauro S, et al.- Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol, 1984, 16, 481-488.
Verin M, Rolland Y, Landgraf F, et al.- New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry, 1995, 59, 579-585.
Cervera R, Piette JC, Font J, et al.- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheumatol, 2002, 46, 1019-1027.
Ducros A, Denier C, Joutel A, et al.- The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med, 2001, 345, 17-24.
Thomsen LL, Ostergaard E, Olesen J, et al.- Evidence for a separate type of migraine with aura: Sporadic hemiplegic migraine. Neurology, 2003, 60, 595-601.
Tournier-Lasserve E, Joutel A, Melki J, et al.- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy maps to chromosome 19p 12. Nat Gen, 1993, 3, 253-259.
Ducros A, Joutel A, Vahedi K, et al.- Mapping of a second locus for familial hemiplegic migraine to 1q21-23 and evidence of further heterogeneity. Ann Neurol, 1997, 42, 885-890.
De Fusco M, Marconi R, Silvestri L, et al.- Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Gen, 2003, 33, 192-196.
Marconi R, De Fusco M, Aridon P, et al.- Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23. Ann Neurol, 2003, 53, 376-381.
Moreno Davilla H.- Molecular and functional diversity of voltage-gated calcium channels. Ann NY Acad Sci, 1999, 868, 102-117.
Plomp JJ, Vergouwe MN, Van den Maagdenberg AM, et al.- Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha (1A) Ca2+ channel mutation. Brain, 2000, 123, 463-471.
Moseley AE, Lieske SP, Wetzel RK, et al.- Na, KATPase a2 isoform is expressed in neurons and its absence disrupts neuronal activity in newborn mice. J Biol Chem, 2003, 27, 5317-5324.
Mobasheri A, Avila J, Cozar-Castellano I, et al.- Na+, K+ - ATPase isoenzyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep, 2000, 20, 51-91.
Ducros A, Tournier-Lasserve E, Bousser MG.- The genetics of migraine. Lancet Neurology, 2002, 1, 285-293.
Zhuchenko O, Bailey J, Bonnen J, et al.- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Gen, 1997, 15, 62-69.
Vanmolkot KR, Kors EE, Hottenga JJ, et al.- Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol, 2003, 54, 360-6.
Casari G, Marconi R, de Fusco M, et al.- Haploinsifficiency of Na, K pump alpha2 subunit gene is responsible for familial hemiplegic migraine type 2. Cephalalgia, 2003, 23, 575.
D'Onofrio M, Ambrosini A Santorelli FM, et al.- A new mutation of the ATP1A2 gene in familial basilar migraine. Cephalalgia, 2004, 24, 149.
Hans M, Luvisetto S, Williams ME, et al.- Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci, 1999, 19, 1610-1619.
Kraus RL, Sinnegger MJ, Koschak A, et al.- Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem, 2000, 275, 9239-9243.
Tottene A, Fellin T, Pagnutti S, et al.- Familial hemiplegic migraine mutations increase Ca(2+) influx through single human Cav2.1 channels and decrease maximal Cav2.1 current density in neurons. Proc Natl Acad Sci USA, 2002, 99, 13284-13289.
Kunkler PE, Kraig RP.- Calcium waves precede electrophysiological changes of spreading depression in hippocampal organ cultures. J Neurosci, 1998, 18, 3416-3426.
Bolay H, Reuter U, Dunn AK, et al.- Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med, 2002, 8, 136-42.
Sappey-Marinier D, Vighetto A, Peyron R, et al.- Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol, 1999, 46, 256-259.
Pietrobon D.- Calcium channels and channelopathies of the central nervous system. Mol Neurobiol, 2002, 25, 31-50.
Weiller C, May A, Limmroth V, et al.- Brainstem activation in spontaneous human migraine attacks. Nat Med, 1995, 1, 658-660.
Van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al.- A Cacnal knockin mouse model with increased susceptibility to cortical spreading depression. Neuron, 2004, 41, 701-710.
Kraig RP, Ferreira-Filho CR, Nicholson C.- Alkaline and acid transients in cerebellar microenvirormement. J Neurophysiol, 1983, 49, 831-850.
May A, Ophoff RA, Terwindt GM, et al.- Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet, 1995, 96, 604-608.
Nyholt DR, Lea RA, Goadsby PJ, et al.- Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology, 1998, 50, 1428-1432.
Terwindt GM, Ophoff RA, van Eijk R, et al.- Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology, 2001, 56, 1028-1032.
Jones KW, Ehm MG, Pericak-Vance MA, et al.- Migraine with aura susceptibility locus on chromosome 19p 13 is dinctinct from the familial hemiplegic migraine locus. Genomics, 2001, 78, 150-154.
Todt U, Heinze A, Zumbroich V, et al.- Systematic analysis of the familial hemiplegic migraine gene ATP1A2 in migraine with aura. Cephalalgia, 2003, 23, 662.
Knight YE, Bartsch T, Kaube H, Goadsby PJ.- P/Q-type calcium-channel blockade in the periaqueducal grey facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci, 2002, 22, RC213.
Asakura K, Kanemasa T, Mibnagawa K, et al. a-Eudesmol, a P/Q-type Ca2+ channel blocker, inhibits neurogenic vasodilatation and extravasation following eletrical stimulation of trigeminal ganglion. Br Res, 2000, 873, 94-101.
Sandor PS, Mascia A, Seidel L, et al.- Subclinical cerebellar impairment in the common types of migraine: a three-dimensional analysis of reaching movements. Ann Neurol, 2001, 49, 668-72.
Harno H, Hirvonen T, Kaunisto MA, et al.- Subclinical vestibulocerebellar dysfunction in migraine with and without aura. Neurology, 2003, 61, 1748-1752.
Neuhauser H, Leopold M, von Brevern M, et al.- The interrelations of migraine, vertigo, and migrainous vertigo. Neurology, 2001, 56, 436-441.
Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia, 2004, 24, 83-91.
Ulrich V, Gervil M, Kyvik KO, et al.- Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol, 1999, 45, 242-246.
Schoenen J, Ambrosini A, Sandor PS, et al.- Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol, 2003, 114, 955-972.
Sandor PS, Dydak U, Schoenen J, et al.- MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura. Cephalalgia, 2004, in press.
Ambrosini A, Garreffa G, Colonnese C, et al.- Cerebellar myo-inositol concentrations are increased in migraine with aura on 1H-NMR spectroscopy: a possible indication of altered Ca2+ homeostasis. Cephalalgia, 2003, 23, 574.
Herzog J, Wilke M, Jurkat-Rott K, et al.- Elevated myo-inositol is indicative for altered Ca2+ homeostasis in the cerebellum of familial hemiplegic migraine patients linked to CACNA1A on chromosome 19p13. J Neurol, 2001, 248, 445.
Westenbroek RE, Hoskins L, Catterall WA.- Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci, 1998, 18, 6319-6330.
Ambrosini A, de Noordhout AM, Alagona G, et al.- Impairment of neuromuscular transmission in a subgroup of migraine patients. Neurosci Lett, 1999, 276, 201-203.
Ambrosini A, Maertens de Noordhout A, Schoenen J.- Neuromuscular transmission in migraine: a single fiber EMG study in clinical subgroups. Neurology, 2001, 56, 1038-1043.
Ambrosini A, Pierelli F, Schoenen J.- Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. Cephalalgia, 2003, 23, 75-8.
Griggs RC, Moxley RT, Lafrance RA, et al.- Hereditary paroxysmal ataxia: response to acetazolamide. Neurology, 1978, 28, 1259-64.
Krivoi II.- Mechanisms of the non-neurotransmitter actions of acetylcholine in the neuromuscular apparatus. Neurosci Behav Physiol, 2002, 32, 149-156.
Estevez M, Gardner K.- Update on the genetics of migraine. Human Genetics, 2004, 114, 225-235.
Lea RA, Shepherd AG, Curtain RG, et al.- A typical migraine susceptibility region localizes to chromosome 1q31. Neurogenetics, 2002, 4, 17-22.
Gardner K, Barmada MM, Ptacek LJ, et al.- A new locus for hemiplegic migraine maps to chromosome 1q31. Cell, 1997, 87, 607-617.
McCarthy LC, Hosford DA, Riley JH, et al.- Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics, 2002, 78, 135-149.
Schroder H, Stovner LJ, Helde G et al.- Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ, 2001, 322, 19-22.
Tronvik E, Stovner LJ, Helde G, et al.- Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomised controlled trial. JAMA, 2003, 289, 65-69.
Valle N, Oterino A, Bravo Y, et al.- 5'-10' methylene-tetrahydrofolate reductase C677T polymorphism influences the risk for experiencing aura among migraineurs. Cephalalgia, 2003, 23, 577.
Schoenen J, Jacquy J, Lenaerts M.- Effectiveness of high-dose riboflavin in migaine prophylaxis. A randomized controlled trial. Neurology, 1998, 50, 466-470.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.